PhreesiaFRA:19P +2.15%65 EV-to-FCF is 11.27 as of Jul. 04, 2026. GuruFocus rates FRA:19P with a GF Score™ of 65/100 and a GF Value™ of €23.45 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Phreesia ranks better than 67% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Phreesia's Enterprise Value is €609.5 Mil.
Phreesia's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 was €54.1 Mil. Therefore, Phreesia's EV-to-FCF for today is 11.27.
The historical rank and industry rank for Phreesia's EV-to-FCF or its related term are showing as below:
FRA:19P'
s EV-to-FCF Range Over the Past 10 Years
Min: -211.72 Med: -16.65 Max: 201.73
Current: 10.96
During the past 9 years, the highest EV-to-FCF of Phreesia was 201.73. The lowest was -211.72. And the median was -16.65.
FRA:19P's EV-to-FCF is ranked better than 67% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.73
vs FRA:19P: 10.96
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Phreesia's share price for today is €9.50.
Phreesia's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.129.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Phreesia EV-to-FCF Related Terms
Phreesia EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Phreesia's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Phreesia's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phreesia EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Phreesia's EV-to-FCF falls into.
Phreesia's current Enterprise Value is €609.5 Mil.
Phreesia's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €54.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phreesia (FRA:19P) has a EV-to-FCF of 11.27 as of Jul. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Phreesia and its competitors. According to the industry distribution chart, Phreesia ranks #134 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 33%.
Is Phreesia's EV-to-FCF too high?
Phreesia's current EV-to-FCF is 11.27. The Healthcare Providers & Services industry median EV-to-FCF is 17.73. Phreesia's value of 11.27 is 36.4% below this industry median. Based on the distribution chart, Phreesia ranks #134 out of 406 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's EV-to-FCF compare to EVH and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Phreesia ranks #134 out of 406 companies for EV-to-FCF. This puts Phreesia in the upper half of its industry. The industry median EV-to-FCF is 17.73. Phreesia's value of 11.27 is 36.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.73, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phreesia's current EV-to-FCF of 11.27 is 36.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Phreesia and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current EV-to-FCF is 11.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (FRA:19P) is currently considered Possible Value Trap. The stock's GF Value™ is €23.45, compared to a current price of €9.50 — trading 59.5% below its estimated fair value. The current EV-to-FCF is 11.27 and 36.4% below the Healthcare Providers & Services industry median of 17.73. Phreesia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Phreesia (FRA:19P), the current EV-to-FCF is 11.27 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phreesia (FRA:19P) Overvalued in 2026?
Based on GuruFocus' analysis, Phreesia stock appears to be undervalued.
The current stock price of €9.50 is trading 59.5% below its estimated GF Value™ of €23.45.
GuruFocus considers Phreesia to be Possible Value Trap.
Key valuation signals for FRA:19P:
EV-to-FCF: 11.27
GF Value™: €23.45 vs. price of €9.50 (59.5% below fair value)
Industry Position: 36.4% below the Healthcare Providers & Services median (#134 of 406)
No single metric tells the full story. See the FRA:19P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score
Get the complete analysis for FRA:19P
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:19P has been successfully added to your 
